DUBLIN – The results of the randomized controlled trial on Neuralign S (formerly Shoulder Pacemaker) in the treatment of functional posterior shoulder instability has been awarded yet another award for Best Paper. This time at the SECEC-ESSSE (European Society for Surgery of the Shoulder and Elbow) 2022 Annual Congress in Dublin.

The scientific recognition of the efficacy of the Neuralign S continues to grow; emphasizing the revolutionary impact of our patented Motion Activated Stimulation™ technology.

Alyve Medical™ would like to congratulate Prof. Philipp Moroder, principal investigator and author of the study, on this achievement!